Nuvaxovid FDA Approval Unlocks Several Bullish Stimuli
Digest more
Top News
Overview
Impacts
Health experts say there are legitimate questions about how much everyone still benefits from yearly COVID vaccination or whether they should be recommended only for people at increased risk.
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.